Retrospective Study
Copyright ©The Author(s) 2025.
World J Stem Cells. Feb 26, 2025; 17(2): 100621
Published online Feb 26, 2025. doi: 10.4252/wjsc.v17.i2.100621
Figure 1
Figure 1 Schematic illustration of the study design. ASCT: Autologous stem cell transplantation; HDCT: High-dose chemotherapy; OS: Overall survival; EFS: Event-free survival; LDH: Lactate dehydrogenase.
Figure 2
Figure 2 Results of Kaplan-Meier analysis of patient overall survival and event-free survival. A and B: Probabilities of overall survival (A) and event-free survival (B) for patients following the first autologous stem cell transplantation; C and D: Overall survival (C) and event-free survival (D) of patients in different groups after the first autologous stem cell transplantation. OS: Overall survival; EFS: Event-free survival.
Figure 3
Figure 3 Results of overall survival and event-free survival analysis for patients with neuroblastoma and other tumors. A and B: Probabilities of overall survival (A) and event-free survival (B) in patients with neuroblastoma and other tumors; C and D: Overall survival (C) and event-free survival (D) of patients with neuroblastoma in different groups. OS: Overall survival; EFS: Event-free survival.